Table 2.
Serovars (n) | Antimicrobial resistance | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
SXT | AMP | AMC | S | DO | CEC | C | FEP | CTX | CIP | IPM | |
S. Enteritidis (48) | 48 | 34 | 42 | 28 | 24 | 20 | 12 | 10 | 6 | 6 | 0 |
S. Typhimurium (36) | 36 | 18 | 22 | 22 | 14 | 18 | 6 | 4 | 4 | 2 | 0 |
S. Kentucky (12) | 12 | 12 | 10 | 10 | 8 | 4 | 2 | 2 | 6 | 4 | 0 |
S. Molade (12) | 12 | 8 | 6 | 8 | 2 | 2 | 0 | 0 | 0 | 0 | 0 |
S. Bargny (6) | 6 | 4 | 2 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
S. Inganda (4) | 4 | 4 | 0 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
S. Infantis (2) | 2 | 2 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total (120) | 120 | 82 | 82 | 78 | 48 | 44 | 20 | 16 | 16 | 12 | 0 |
a Resistant % | 100% | 68.% | 68.% | 65% | 40% | 36.7% | 16.7% | 13.3% | 13.3% | 10% | 0 |
a Intermediate % | 0 | 4.2% | 0 | 8.3% | 10.8% | 12.5% | 16.7% | 0 | 5.8% | 0 | 0 |
a Susceptible % | 0 | 27.5% | 36.7% | 26.7% | 49.2% | 50.8% | 66.7% | 86.7% | 80.8% | 90% | 100% |
AMC Amoxicillin-clavulanic acid, AMP Ampicillin, CEC Cefaclor, CTX Cefotaxime, FEP Cefepime, DO Doxycycline, CIP Ciprofloxacin, IPM Imipenem, S Streptomycin, C Chloramphenicol and SXT Trimethoprim sulfamethoxazole
aThe percentage of the total number of isolates resistant, intermediate, or susceptible for a particular antimicrobial is indicated in the last three rows below each antimicrobial